Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2005
08/25/2005WO2005078137A1 Methods and apparati using single polymer analysis
08/25/2005WO2005078136A1 Method of prognosis of metastasis by detection of fra12e fragile site within the smrt gene/locus at chromosome 12q24
08/25/2005WO2005078135A1 Method for identification of the location of mutations in whole genomes
08/25/2005WO2005078134A2 Gene profiling of human embryonic stem cells
08/25/2005WO2005078132A2 OLIGONUCLEOTIDE PROBES FOR DIAGNOSIS AND IDENTIFICATION OF THE DIFFERENT FORMS OF β-THALASSEMIA, METHODS AND DIAGNOSTIC KIT THEREOF
08/25/2005WO2005078131A1 Tb resistance assay
08/25/2005WO2005078130A1 Arrayed polynucleotides
08/25/2005WO2005078129A2 Thrombosis diagnosis/prognosis method
08/25/2005WO2005078128A1 Method for detecting the risk of preeclampsia by analysing a dimethylarginine dimethylaminohydrolase gene
08/25/2005WO2005078127A1 Method for detecting the risk of cancer, coronary heart disease, and stroke by analysing a catalase gene
08/25/2005WO2005078126A2 Means for detecting and treating cancer cells resistant to therapeutic agents
08/25/2005WO2005078125A2 Itpase gene polymorphisms associated with adverse drug reactions to azathioprine therapy
08/25/2005WO2005078124A2 Diagnostic marker for cancer
08/25/2005WO2005078122A2 Method for enrichment involving elimination by mismatch hybridisation
08/25/2005WO2005078121A1 CpG-AMPLICON AND ARRAY PROTOCOL
08/25/2005WO2005078120A1 Device for salmonella detection and method of use thereof
08/25/2005WO2005078119A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same
08/25/2005WO2005078118A1 Oxidizable species as an internal reference for biosensors and method of use
08/25/2005WO2005078115A1 Process for large scale production of plasmid dna by e. coli fermentation
08/25/2005WO2005078106A1 Orotate transporter encoding marker genes
08/25/2005WO2005078102A1 Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray
08/25/2005WO2005078100A1 Method of detecting cancer cell acquiring drug-resistance
08/25/2005WO2005078099A1 Mecp2e1 gene
08/25/2005WO2005078096A2 Dual functional oligonucleotides for use in repressing mutant gene expression
08/25/2005WO2005078092A1 Method of detecting and identifying gram-negative obligative anaerobic bacterium
08/25/2005WO2005078089A1 Method for producing sirna molecules and sirna molecules produced therewith
08/25/2005WO2005078087A1 Antibody targeting osteoclast-associated protein
08/25/2005WO2005078086A1 Method of detecting and identifying lactic acid bacterium
08/25/2005WO2005078082A1 Method of constructing probe dna for nucleic acid encoding membrane protein, method of detecting the expression of gene encoding membrane protein and probe dna immobilization support
08/25/2005WO2005078080A1 Mutation associated with lacunar strokes
08/25/2005WO2005078072A1 Regulatory cell controlling immunological activity of t cell
08/25/2005WO2005077983A2 Modulating p38 kinase activity
08/25/2005WO2005077974A1 IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM
08/25/2005WO2005077125A2 Methods and compositions for detecting nucleic acids
08/25/2005WO2005077084A2 Krüppel-like transcriptional factor klf4/gklf and uses thereof
08/25/2005WO2005077007A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
08/25/2005WO2005076984A2 Thymidylate synthase gene and metastasis
08/25/2005WO2005076979A2 Diagnosis and therapeutics for cancer
08/25/2005WO2005076975A2 Complexed polypeptide and adjuvant for improved vaccines
08/25/2005WO2005076939A2 Assay and method for diagnosing and treating alzheimer’s disease
08/25/2005WO2005076925A2 Dutp based compositions for reducing primer-aggregate formation during nucleic acid amplification
08/25/2005WO2005076908A2 Anti-freeze protein enhanced nucleic acid amplification
08/25/2005WO2005076893A2 Compositions and methods for determining the replication capacity of a pathogenic virus
08/25/2005WO2005076892A2 Method for determining reduced susceptibility of hiv to protease inhibitor treatment
08/25/2005WO2005076887A2 Methods and systems for sampling, screening, and diagnosis
08/25/2005WO2005076837A2 Method for detection of promoter methylation status
08/25/2005WO2005076786A2 Colon carcinoma related oligonucleotides and methods of use
08/25/2005WO2005076784A2 Methods for detecting dna viruses
08/25/2005WO2005063816A3 Monovalent antibody fragments useful as therapeutics
08/25/2005WO2005062952A3 Compositions and methods for modulating sirtuin activity
08/25/2005WO2005062918A3 Methods of treating asthma
08/25/2005WO2005054507A3 Genes associated with colorectal cancer
08/25/2005WO2005054506A3 Methods for detecting vdj recombination
08/25/2005WO2005054431A9 Method for isolation of independent, parallel chemical micro-reactions using a porous filter
08/25/2005WO2005047543A3 Ligation assay
08/25/2005WO2005047537A3 Diagnosis of distal hereditary motor neuropathy type ii by detection of hsp22 gene polymorphisms
08/25/2005WO2005047320A3 Equine p-selection glycoprotein ligand-1 and uses thereof
08/25/2005WO2005045433A3 Method for distinguishing aml subtypes with aberrant and prognostically intermediate karyotypes
08/25/2005WO2005043170A3 Ubiquitin-based protein interaction assays and related compositions
08/25/2005WO2005040429A3 Amplification of signal using a bead-based oligonucleotide assay
08/25/2005WO2005037194A3 Collagen interactions with prostate cancer cells
08/25/2005WO2005030925A9 Microfluidic rotary flow reactor matrix
08/25/2005WO2005028615A3 Methods and compositions for detecting promoter activity and expressing fusion proteins
08/25/2005WO2005026692A3 Direct detection method for products of cellular metabolism using tof-sims
08/25/2005WO2005019831A3 Methods for reducing complexity of a sample using small epitope antibodies
08/25/2005WO2005010200A3 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis
08/25/2005WO2004087069A3 METHODS OF IDENTIFYING COMPOUNDS THAT TARGET tRNA SPLICING ENDONUCLEASE AND USES OF SAID COMPOUNDS AS ANTI-PROLIFERATIVE AGENTS
08/25/2005WO2004074810A3 Signalling compounds for use in methods of detecting hydrogen peroxide
08/25/2005WO2004072228A3 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
08/25/2005WO2004059276A3 Rna bioassay
08/25/2005WO2004043988A8 Ptprk immunogenic peptide
08/25/2005WO2004042071A3 Detection and typing of human papillomavirus using pna probes
08/25/2005WO2004009851A3 Method for pcr cleanup and oligonucleotide removal
08/25/2005WO2003067220A3 A method of effecting angiogenesis by modulating the function of a novel endothelia phosphatase
08/25/2005US20050188435 Method of increasing the GGT activity in plants, plants with increased GGT activity, and a method of producing such plants
08/25/2005US20050188427 Lysyl oxidase-like 1 (LOXL1) and elastogenesis
08/25/2005US20050187383 Oligonucleotide conjugates; peptide nucleic acids; sequencing; for treating cancer
08/25/2005US20050187379 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/25/2005US20050187175 Methods and compositions for CPG15-2
08/25/2005US20050187154 bone morphogenetic proteins play an important role in adipocyte differentiation; promote brown adipocyte tissue (BAT) differentiation and inhibits white adipose tissue (WAT) adipogenesis
08/25/2005US20050187150 mimics the binding of heparin and heparan sulfate to the fibroblast growth factor (FGF) ligand and receptor; ternary complex of:an FGF ligand polypeptide; an FGF receptor polypeptide; and a heparin agonist or antagonist
08/25/2005US20050187141 Control of gene induced by oxidated lipids in human artery wall cells
08/25/2005US20050186684 Simultaneously testing a sample for the presence, absence and/or amount of one or more selected analytes; gene expression analysis
08/25/2005US20050186670 Method of detecting error spot in DNA chip and system using the method
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186653 Compositions and methods for screening antibacterial compounds
08/25/2005US20050186652 By contacting sample with reductase or redox agent; electrolytic cells
08/25/2005US20050186651 Incubating the drug candidate in vitro with a human liver microsome incubation mixture in the presence of dansylated glutathione; detecting any drug candidate-dansylated glutathione adducts formed using a fluorescence detector
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186649 Inhibitors of human plasmin derived from the kunitz domains
08/25/2005US20050186648 Using optical coherence tomography (OCT) for use in monitoring blood glucose and diagnosing diabetes
08/25/2005US20050186646 Rapid assay to detect ADAMTS-13 activity
08/25/2005US20050186631 Nematode PPPT-like sequences
08/25/2005US20050186624 Identifying preferential transcription and/or translational products using luminescent detectors
08/25/2005US20050186622 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
08/25/2005US20050186619 Nucleic acid analysis using terminal-phosphate-labeled nucleotides
08/25/2005US20050186617 Transgenic cell comprising vitamin d3 receptor for use as gene expression diagnostic tool which monitor conversion of ligand precursors into ligands
08/25/2005US20050186616 Nucleotide sequences coding cysteine proteinase inhibitors for use in identifying modulators for prevention and treatment of cell proliferative disorders
08/25/2005US20050186614 Breast cancer genes for use as diagnostic indicator ataxia telangiectasia
08/25/2005US20050186611 Method and apparatus for manufacturing microarray
1 ... 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 ... 3003